Multiple sclerosis, immunomodulators, and pregnancy outcome: a prospective observational study

Background There is still uncertainty about the management of pregnant women exposed to immunomodulatory therapy for treatment of multiple sclerosis (MS) in pregnancy. Objective To assess the safety of interferon (IFN)-β1a, IFN-β1b, and glatiramer acetate (GA) for treatment of MS during pregnancy. Methods A prospective observational cohort study was performed with patients enrolled through a drug risk assessment by the Teratology Information...